Palladia Revenue and Competitors
Estimated Revenue & Valuation
- Palladia's estimated annual revenue is currently $15M per year.
- Palladia's estimated revenue per employee is $67,568
Employee Data
- Palladia has 222 Employees.
- Palladia grew their employee count by 0% last year.
Palladia's People
Name | Title | Email/Phone |
---|---|---|
1 | Program Director | Reveal Email/Phone |
2 | Assistant Director | Reveal Email/Phone |
3 | Program Director | Reveal Email/Phone |
4 | Program Manager | Reveal Email/Phone |
5 | Case Manager | Reveal Email/Phone |
6 | Case Manager | Reveal Email/Phone |
7 | Manager | Reveal Email/Phone |
8 | Sr. House Manager | Reveal Email/Phone |
9 | social worker | Reveal Email/Phone |
10 | Diversion Supervisor | Reveal Email/Phone |
Palladia Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $284.3M | 257 | 9% | N/A | $502.4M |
#2 | $35M | 99 | 6% | N/A | N/A |
What Is Palladia?
Non-Profit & Professional Orgs.
keywords:N/AN/A
Total Funding
222
Number of Employees
$15M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Palladia News
2022-04-06 - Obavy z inflace a riziko recese podporují drahé kovy
V souvislosti s p?eruením dodávek o?ekává BMO Capital Markets pr?m?rnou cenu palladia ve druhém ?tvrtletí 2 700 USD za unci a spotovou cenu nad...
2022-03-30 - Must See' Sprawling Ranch Hits The Market In Wallingford
The impressive Primary Bedroom Suite boasts cathedral ceiling, skylights, palladia window, tile floor, large walk-in closet and slider to...
2022-03-30 - Orum Therapeutics Announces Formation of Scientific Advisory Board
She has been a key contributor to the successful development of multiple FDA-approved products, including SUTENT®, PALLADIA®, VISTIDE®,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $40.3M | 222 | -9% | N/A |
#2 | $58.7M | 222 | 5% | N/A |
#3 | $35.4M | 222 | 6% | N/A |
#4 | $41.4M | 222 | -3% | N/A |
#5 | $54.2M | 222 | -11% | $57.5M |